EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:132314 - demethylzeylasteral
| Formula | C29H36O6 |
| Net Charge | 0 |
| Average Mass | 480.601 |
| Monoisotopic Mass | 480.25119 |
| SMILES | [H]C(=O)c1c(O)c(O)cc2c1C(=O)C=C1[C@@]2(C)CC[C@@]2(C)[C@]3([H])C[C@](C)(C(=O)O)CC[C@]3(C)CC[C@]12C |
| InChI | InChI=1S/C29H36O6/c1-25-6-7-26(2,24(34)35)14-21(25)29(5)11-9-27(3)17-12-19(32)23(33)16(15-30)22(17)18(31)13-20(27)28(29,4)10-8-25/h12-13,15,21,32-33H,6-11,14H2,1-5H3,(H,34,35)/t21-,25-,26-,27+,28-,29+/m1/s1 |
| InChIKey | ZDZSFWLPCFRASW-CPISFEQASA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Tripterygium wilfordii (ncbitaxon:458696) | - | PubMed (22874791) |
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Roles: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. EC 2.4.1.17 (glucuronosyltransferase) inhibitor A EC 2.4.1.* (hexosyltransferase) inhibitor that inhibits the action of glucuronosyltransferase (EC 2.4.1.17). plant metabolite Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
| Applications: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. anti-inflammatory agent Any compound that has anti-inflammatory effects. nephroprotective agent Any protective agent that is able to prevent damage to the kidney. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| demethylzeylasteral (CHEBI:132314) has role anti-inflammatory agent (CHEBI:67079) |
| demethylzeylasteral (CHEBI:132314) has role EC 2.4.1.17 (glucuronosyltransferase) inhibitor (CHEBI:133811) |
| demethylzeylasteral (CHEBI:132314) has role immunosuppressive agent (CHEBI:35705) |
| demethylzeylasteral (CHEBI:132314) has role nephroprotective agent (CHEBI:76595) |
| demethylzeylasteral (CHEBI:132314) has role plant metabolite (CHEBI:76924) |
| demethylzeylasteral (CHEBI:132314) is a arenecarbaldehyde (CHEBI:33855) |
| demethylzeylasteral (CHEBI:132314) is a benzenediols (CHEBI:33570) |
| demethylzeylasteral (CHEBI:132314) is a carbopolycyclic compound (CHEBI:35294) |
| demethylzeylasteral (CHEBI:132314) is a cyclic ketone (CHEBI:3992) |
| demethylzeylasteral (CHEBI:132314) is a enone (CHEBI:51689) |
| demethylzeylasteral (CHEBI:132314) is a oxo monocarboxylic acid (CHEBI:35871) |
| IUPAC Name |
|---|
| (2R,4aS,6aS,12bR,14aS,14bR)-9-formyl-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-8-oxo-1,2,3,4,4a,5,6,6a,8,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid |
| Citations |
|---|